Genelux GNLX
NASDAQ GNLX
$1.98 -0.09 (-4.35%)
At close: Oct 22, 2026 · 4:00 PM EDT

Genelux (GNLX) Return on Assets [ROA] (2023 - 2026)

Updated

Genelux's Return on Assets [ROA] was -131.79% in Q1 2026, up 15.91 percentage points from the prior quarter.

Analysis

Genelux (GNLX) Return on Assets [ROA] (2023 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Genelux came in at -120.96%, down 21.94 percentage points from FY2024.

  • In earlier years, Return on Assets [ROA] was -99.01% in FY2024 (+44.34 pp) and -143.35% in FY2023.
  • Quarterly Return on Assets [ROA] has moved between -147.69% (Q4 2025) and -65.37% (Q3 2024) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 8.08%
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 4.65%
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 2.45%
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 10.60%
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 9.10%
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 9.29%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -6.13%
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 2.14%
10 Genelux 88.08 Mn 26.36 Mn - -131.79%
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -131.79%
Dec 31, 2025 -147.69%
Sep 30, 2025 -114.50%
Dec 31, 2024 -82.27%
Sep 30, 2024 -65.37%
Jun 30, 2024 -76.03%
Mar 31, 2024 -95.54%
Dec 31, 2023 -77.04%
API Access

Genelux Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=GNLX&period=max&api_key=YOUR_API_KEY